K-111

 

Topic mentions per year

Topic mentions per year

2000-2006
0120002006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The relationship between adipocytes and infiltrated macrophages in fat tissue is important for the pathogenesis of insulin… (More)
Is this relevant?
Review
2007
Review
2007
Kozva Co Ltd, under license from Roche Holding AG, is developing K-111, an orally available peroxisome proliferator-activated… (More)
Is this relevant?
Review
2006
Review
2006
INTRODUCTION Prevalence of the metabolic syndrome has increased dramatically in recent years. Optimal patient care demands a… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2005
2005
Insulin covalently and allosterically regulates glycogen synthase (GS) and may also cause the translocation of GS from glycogen… (More)
Is this relevant?
2004
2004
K-111 has been characterized as a potent peroxisome proliferator-activated receptor (PPAR)alpha activator. Antidiabetic potency… (More)
Is this relevant?
2003
2003
K-111, formerly BM 17.0744, (2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid) is a new insulin-sensitizer with peroxisome… (More)
Is this relevant?
2002
2002
This study was undertaken to investigate the hypocholesterolemic activity of Bifidobacteria (B. breve K-110, B. breve K-111, and… (More)
Is this relevant?
2001
2001
Panax ginseng is widely used as a Chinese medicine, but it takes a long time to reach harvest and to establish its qualified… (More)
Is this relevant?
2000
2000
The antitumor activity of Bifidobacterium breve K-110, and K-111, and B. infantis K-525 was investigated. These Bifidobacterial… (More)
Is this relevant?